Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-12

Clinical Trial Update: A Trial of the Efficacy and Safety of Izokibep in the Treatment of Non-anterior Uveitis [Phase 2]

View source ↗

Summary

Phase 2 trial update for izokibep assessing efficacy and safety in non-anterior uveitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Izokibep (izokibep)

Snippet

Sponsor: ACELYRIN Inc. | Conditions: Uveitis | Phase 2 | Status: COMPLETED